Jennison Associates LLC Longboard Pharmaceuticals, Inc. Transaction History
Jennison Associates LLC
- $155 Billion
- Q2 2024
A detailed history of Jennison Associates LLC transactions in Longboard Pharmaceuticals, Inc. stock. As of the latest transaction made, Jennison Associates LLC holds 951,968 shares of LBPH stock, worth $56.4 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
951,968
Previous 942,404
1.01%
Holding current value
$56.4 Million
Previous $20.4 Million
26.41%
% of portfolio
0.02%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding LBPH
# of Institutions
103Shares Held
34.2MCall Options Held
8.5KPut Options Held
31.1K-
Ra Capital Management, L.P. Boston, MA3.29MShares$195 Million1.34% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.94MShares$174 Million0.38% of portfolio
-
Cormorant Asset Management, LP Boston, MA2.79MShares$165 Million5.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.51MShares$149 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$140 Million0.0% of portfolio
About Longboard Pharmaceuticals, Inc.
- Ticker LBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,586,000
- Market Cap $804M
- Description
- Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical ...